Effect of filarial infection on serum inflammatory and atherogenic biomarkers in coronary artery disease (CURES-121)

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 5, 2012, Pages 828-833

  Aravindhan, Vivekanandhan ^a,f   Mohan, Viswanathan ^b,f   Surendar, Jayagopi ^b,f   Rao, Maradana Muralidhara ^b,f   Anuradha, Rajamanickam ^c,f   Deepa, Mohan ^b,f   Babu, Subash ^c,d,e,f  

^a ANNA UNIVERSITY   (India)

^b MADRAS DIABETES RESEARCH FOUNDATION   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^e SAIC FREDERICK INC   (United States)

^f Dr Mohan's Diabetes Specialties Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPSIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOMODULATION; LYMPHATIC FILARIASIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; ELEPHANTIASIS, FILARIAL; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; INDIA; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RURAL POPULATION; TUMOR NECROSIS FACTOR-ALPHA;

VERMES;

EID: 84861825528     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0773     Document Type: Article

References (29)

1. Murray CJ, Lopez AD, 1997. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 349: 1498-1504.
2. Gupta R, Misra A, Pais P, Rastogi P, Gupta VP, 2006. Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factors. Int J Cardiol 108: 291-300.
3. Choudhury RP, Fisher EA, 2009. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol 29: 983-991.
4. Nieto FJ, 1999. Viruses and atherosclerosis: a critical review of the epidemiologic evidence. Am Heart J 138: S453-S460.
5. Shah PK, 2001. Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? Circulation 103: 5-6.
6. van Riet E, Hartgers FC, Yazdanbakhsh M, 2007. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 212: 475-490.
7. Self LS, 1998. A different perspective on global mapping of lymphatic filariasis. Parasitol Today 14: 333.
8. Aravindhan V, Mohan V, Surendar J, Rao MM, Ranjani H, Kumaraswami V, Nutman TB, Babu S, 2010. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg 83: 1336-1339.
9. Aravindhan V, Mohan V, Surendar J, Muralidhara Rao M, Pavankumar N, Deepa M, Rajagopalan R, Kumaraswami V, Nutman TB, Babu S, 2010. Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83). PLoS Negl Trop Dis 4: e707.
10. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V, 2003. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I). J Assoc Physicians India 51: 863-870.
11. Mohan V, Ravikumar R, Shanthi Rani S, Deepa R, 2000. Intimal medial thickness of the carotid artery in South Indian diabetic and non-diabetic subjects: the Chennai Urban Population Study (CUPS). Diabetologia 43: 494-499.
12. Gokulakrishnan K, Deepa R, Mohan V, 2008. Association of high sensitivity C-reactive protein (hsCRP) and tumor necrosis factor-alpha (TNF-alpha) with carotid intimal medial thickness in subjects with different grades of glucose intolerance-the Chennai Urban Rural Epidemiology Study (CURES-31). Clin Biochem 41: 480-485.
13. Pignoli P, Longo T, 1986. Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments. Eur Surg Res 18: 238-253.
14. Lonn EM, Yusuf S, Doris CI, Sabine MJ, Dzavik V, Hutchison K, Riley WA, Tucker J, Pogue J, Taylor W, 1996. Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE. Am J Cardiol 78: 914-919.
15. Cooke A, 2009. Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes? Immunology 126: 12-17.
16. Weinstock JV, Elliott DE, 2009. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 15: 128-133.
17. Harnett MM, Melendez AJ, Harnett W, 2010. The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol 159: 256-267.
18. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK, Chawla A, Locksley RM, 2011. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332: 243-247.
19. Jacobs M, van Greevenbroek MM, van der Kallen CJ, Ferreira I, Blaak EE, Feskens EJ, Jansen EH, Schalkwijk CG, Stehouwer CD, 2009. Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 39: 437-444.
20. Hogh AL, Joensen J, Lindholt JS, Jacobsen MR, Ostergaard L, 2008. C-reactive protein predicts future arterial and cardiovascular events in patients with symptomatic peripheral arterial disease. Vasc Endovascular Surg 42: 341-347.
21. Bell DS, 2000. Inflammation, insulin resistance, infection, diabetes, and atherosclerosis. Endocr Pract 6: 272-276.
22. Campbell LA, Yaraei K, Van Lenten B, Chait A, Blessing E, Kuo CC, Nosaka T, Ricks J, Rosenfeld ME, 2010. The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis. Microbes Infect 12: 598-606.
23. Kebschull M, Demmer RT, Papapanou PN, 2010. "Gum bug, leave my heart alone!"-epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J Dent Res 89: 879-902.
24. Kusters JG, Kuipers EJ, 1999. Helicobacter and atherosclerosis. Am Heart J 138: S523-S527.
25. Lal RB, Ottesen EA, 1988. Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment. J Infect Dis 158: 1034-1037.
26. Hunter MM, Wang A, McKay DM, 2007. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 132: 1320-1330.
27. Matsuzawa Y, Shimomura I, Kihara S, Funahashi T, 2003. Importance of adipocytokines in obesity-related diseases. Horm Res 60 (Suppl 3): 56-59.
28. Matarese G, Mantzoros C, La Cava A, 2007. Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis. Curr Pharm Des 13: 3676-3680.
29. Hasan-Ali H, Abd El-Mottaleb NA, Hamed HB, Abd-Elsayed A, 2011. Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coron Artery Dis 22: 264-269.